Yaygın evre küçük hücreli akciğer kanserinde lenfosit/C-reaktif protein oranının prognostik önemi-Reference-Cited by-同舟云学术

Yaygın evre küçük hücreli akciğer kanserinde lenfosit/C-reaktif protein oranının prognostik önemi

Published:2023-08-30 Issue:4 Volume:4 Page:341-344
ISSN:2717-7505
Container-title:Journal of Medicine and Palliative Care
language:
Short-container-title:

Author:

ÖZTÜRK ERGÜR Figen¹^ORCID,ÖZTÜRK Ayperi²^ORCID,UZEL ŞENER Melahat²^ORCID,SAYMAZ Zeynep Tilbe²^ORCID,MUTLU Nihal²

Affiliation:

1. Ankara Atatürk Sanatoryum Eğitim ve araştırma Hastanesi

2. SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA ATATÜRK GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ

Abstract

Aims: We aimed to investigate the pre-treatment prognostic significance of lymphocyte/C-Reactive protein ratio (LCR), one of the inflammatory factors, in patients with extensive-stage small cell lung cancer (SCLC). Methods: Medical records of 514 patients who were diagnosed with extensive-stage SCLC between 2010 and 2020 were examined retrospectively. LCR was calculated using the blood test results prior to chemotherapy. Results: The mean survival time for extensive-stage SCLC is 6 months (5.3-6.7). A statistically significant difference exists between limited and extensive stages in terms of median overall survival (OS) (p

Funder

yok

Publisher

Journal of Medicine and Palliative Care

Subject

General Medicine

Reference14 articles.

1. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006;24(28):4539-4544.

2. Bernhardt EB, Jalal SI. Small cell lung cancer. Cancer Treat Res. 2016;170:301-322.

3. Cerny T, Blair V, Anderson H, Bramwell V, Thatcher N. Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer. 1987;39(2):146-149.

4. Greten FR, Grivennikov SI. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019;51(1):27-41.

5. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008; 454(7203):436-444.